Per Bergström

4.2k total citations
13 papers, 435 citations indexed

About

Per Bergström is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Per Bergström has authored 13 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 4 papers in Radiation. Recurrent topics in Per Bergström's work include Lung Cancer Diagnosis and Treatment (4 papers), Advanced Radiotherapy Techniques (4 papers) and Cancer Treatment and Pharmacology (2 papers). Per Bergström is often cited by papers focused on Lung Cancer Diagnosis and Treatment (4 papers), Advanced Radiotherapy Techniques (4 papers) and Cancer Treatment and Pharmacology (2 papers). Per Bergström collaborates with scholars based in Sweden, Norway and Denmark. Per Bergström's co-authors include Rolf Lewensohn, Jan Nyman, Ingmar Lax, Andreas Hallqvist, Signe Friesland, Bengt Bergman, Jo-Åsmund Lund, Erik Holmberg, Roger Henriksson and Uwe Schlegel and has published in prestigious journals such as British Journal of Cancer, European Journal of Cancer and Radiotherapy and Oncology.

In The Last Decade

Per Bergström

12 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Per Bergström Sweden 8 284 170 119 84 69 13 435
Stefano Vagge Italy 13 180 0.6× 166 1.0× 161 1.4× 72 0.9× 85 1.2× 39 472
Herman D. Suit United States 9 272 1.0× 83 0.5× 90 0.8× 72 0.9× 61 0.9× 9 553
Vikram Rao Bollineni Netherlands 10 202 0.7× 61 0.4× 325 2.7× 34 0.4× 31 0.4× 20 507
Masakazu Ogura Japan 11 174 0.6× 58 0.3× 86 0.7× 70 0.8× 61 0.9× 29 368
Shichuan Zhang United States 6 346 1.2× 306 1.8× 209 1.8× 68 0.8× 243 3.5× 9 768
A.L. Zietman United States 12 391 1.4× 150 0.9× 72 0.6× 18 0.2× 74 1.1× 39 570
Z. Özen Türkiye 9 60 0.2× 72 0.4× 77 0.6× 26 0.3× 36 0.5× 19 326
Kenneth Bastin United States 10 111 0.4× 58 0.3× 58 0.5× 64 0.8× 66 1.0× 15 318
S. Tubin Austria 13 276 1.0× 192 1.1× 206 1.7× 18 0.2× 30 0.4× 30 512
Su-Mi Chung South Korea 11 85 0.3× 53 0.3× 29 0.2× 60 0.7× 54 0.8× 15 399

Countries citing papers authored by Per Bergström

Since Specialization
Citations

This map shows the geographic impact of Per Bergström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Bergström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Bergström more than expected).

Fields of papers citing papers by Per Bergström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Bergström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Bergström. The network helps show where Per Bergström may publish in the future.

Co-authorship network of co-authors of Per Bergström

This figure shows the co-authorship network connecting the top 25 collaborators of Per Bergström. A scholar is included among the top collaborators of Per Bergström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Bergström. Per Bergström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lindberg, Karin, Per Bergström, Odd Terje Brustugun, et al.. (2017). OA24.05 The Nordic HILUS-Trial - First Report of a Phase II Trial of SBRT of Centrally Located Lung Tumors. Journal of Thoracic Oncology. 12(1). S340–S340. 38 indexed citations
2.
Nyman, Jan, Andreas Hallqvist, Jo-Åsmund Lund, et al.. (2016). SPACE – A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiotherapy and Oncology. 121(1). 1–8. 222 indexed citations
3.
Nyman, Jan, Andreas Hallqvist, O.T. Brustugun, et al.. (2014). OC-0565: SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiotherapy and Oncology. 111. S221–S221. 14 indexed citations
4.
Lindvall, Peter, et al.. (2009). Radiation Schedules in Relation to Obliteration and Complications in Hypofractionated Conformal Stereotactic Radiotherapy of Arteriovenous Malformations. Stereotactic and Functional Neurosurgery. 88(1). 24–28. 9 indexed citations
5.
Reardon, David A., G. Dresemann, Sophie Taillibert, et al.. (2009). Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. British Journal of Cancer. 101(12). 1995–2004. 100 indexed citations
6.
Johansson, Anders, Kjell Grankvist, Jan Andersson, et al.. (2006). Verotoxin-1 induction of apoptosis in Gb3-expressing human glioma cell lines. Cancer Biology & Therapy. 5(9). 1211–1217. 18 indexed citations
7.
Bergström, Per, et al.. (2005). Adenylate Cyclase Toxin From Bordetella pertussis Enhances Cisplatin-Induced Apoptosis to Lung Cancer Cells In Vitro. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 15(9). 423–430. 7 indexed citations
8.
Bergström, Per, et al.. (2004). [Joint Center--a collaboration project for optimal decentralized radiotherapy].. PubMed. 101(6). 472–5. 2 indexed citations
9.
Bergström, Per, Anders Johnsson, Tommy Bergenheim, & Roger Henriksson. (1999). Effects of Amifostine on Cisplatin Induced DNA Adduct Formation and Toxicity in Malignant Glioma and Normal Tissues in Rat. Journal of Neuro-Oncology. 42(1). 13–21. 9 indexed citations
10.
Vallbo, Christina, A. Tommy Bergenheim, Per Bergström, P. O. Gunnarsson, & Roger Henriksson. (1998). Apoptotic tumor cell death induced by estramustine in patients with malignant glioma.. PubMed. 4(1). 87–91. 8 indexed citations
11.
Salander, Pär, A. Tommy Bergenheim, Per Bergström, & Roger Henriksson. (1997). How to tell cancer patients — A contribution to a theory of diagnosis-communication. European Journal of Cancer. 33. S62–S62. 1 indexed citations
12.
Bergström, Per, Kjell Grankvist, S. E. Holm, & Roger Henriksson. (1991). Effects of antimicrobial drugs on the cytotoxicity of epirubicin, bleomycin, estramustine and cisplatin.. PubMed. 11(3). 1039–43. 6 indexed citations
13.
Bergström, Per, et al.. (1990). [Interactions between cytostatic agents and other drugs].. PubMed. 105(12). 335–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano Vagge Breakdown of academic impact, for papers by Herman D. Suit Breakdown of academic impact, for papers by Vikram Rao Bollineni Breakdown of academic impact, for papers by Masakazu Ogura Breakdown of academic impact, for papers by Shichuan Zhang Breakdown of academic impact, for papers by A.L. Zietman Breakdown of academic impact, for papers by Z. Özen Breakdown of academic impact, for papers by Kenneth Bastin Breakdown of academic impact, for papers by S. Tubin Breakdown of academic impact, for papers by Su-Mi Chung
Rankless by CCL
2026